COMPARATIVE ACTIVITY OF HUMAN AND MURINE TUMOR-NECROSIS-FACTOR IN TOXICITY AND ANTIINFECTIOUS ASSAYS IN MICE

被引:6
作者
PARANT, F
TAVERNIER, J
FIERS, W
PARANT, M
机构
[1] UNIV PARIS 06,IMMUNOPHARMACOL LAB,CNRS,UPR 405,15 RUE ECOLE MED,F-75270 PARIS 06,FRANCE
[2] BIOGENT,B-9000 GHENT,BELGIUM
[3] LAB MOLEC BIOL,B-9000 GHENT,BELGIUM
关键词
bacterial infections; TNF; toxicity;
D O I
10.1016/0882-4010(90)90078-5
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In comparative experiments, the lethal effect of rHuTNF or rMuTNF was evaluated in animals sensitized by adrenalectomy or galactosamine treatment. No clear-cut difference was observed in the effective dose irrespective of the origin of the TNF preparation in Swiss or in C3H/HeJ mice. The latter mouse substrain known to be a low responder to LPS was used in the assays to evaluate the influence of LPS contamination in TNF-induced responses. Like LPS, TNF was shown to induce abortion in pregnant mice, and the mortality rate of foetuses was almost the same in animals challenged with either rHuTNF or rMuTNF. No species preference was apparent in the protective effect of TNF against a bacterial challenge. In adult mice subsequently infected with Klebsiella pneumoniae or Listeria monocytogenes, the survival rate was comparable in groups treated with both TNF preparations. In contrast, in young mice rHuTNF and rMuTNF were ineffective against Listeria and poorly active against Klebsiella organisms, whereas a significant effect was obtained with crude mouse serum containing TNF. © 1990.
引用
收藏
页码:143 / 149
页数:7
相关论文
共 20 条
  • [1] BERTINI T, 1988, J EXP MED, V167, P1708
  • [2] SPECIES SPECIFICITY AND INVOLVEMENT OF OTHER CYTOKINES IN ENDOTOXIC-SHOCK ACTION OF RECOMBINANT TUMOR NECROSIS FACTOR IN MICE
    BROUCKAERT, PG
    EVERAERDT, B
    LIBERT, C
    TAKAHASHI, N
    FIERS, W
    [J]. AGENTS AND ACTIONS, 1989, 26 (1-2): : 196 - 198
  • [3] GENE CLONING AND STRUCTURE - FUNCTION RELATIONSHIP OF CYTOKINES SUCH AS TNF AND INTERLEUKINS
    FIERS, W
    BEYAERT, R
    BROUCKAERT, P
    EVERAERDT, B
    HAEGEMAN, G
    SUFFYS, P
    TAVERNIER, J
    VANDENABEELE, P
    VANHAESEBROECK, B
    VANOSTADE, X
    VANROY, F
    [J]. IMMUNOLOGY LETTERS, 1987, 16 (3-4) : 219 - 226
  • [4] RECOMBINANT TUMOR-NECROSIS-FACTOR - SPECIES SPECIFICITY FOR A VARIETY OF HUMAN AND MURINE TRANSFORMED-CELL LINES
    FRANSEN, L
    RUYSSCHAERT, MR
    VANDERHEYDEN, J
    FIERS, W
    [J]. CELLULAR IMMUNOLOGY, 1986, 100 (01) : 260 - 267
  • [5] HAVELL EA, 1987, J IMMUNOL, V139, P4225
  • [6] KRAMER SM, 1988, CANCER RES, V48, P920
  • [7] LETHAL TOXICITY OF LIPOPOLYSACCHARIDE AND TUMOR-NECROSIS-FACTOR IN NORMAL AND D-GALACTOSAMINE-TREATED MICE
    LEHMANN, V
    FREUDENBERG, MA
    GALANOS, C
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 165 (03) : 657 - 663
  • [8] MANDA T, 1988, CANCER RES, V48, P4250
  • [9] MOLECULAR-CLONING AND EXPRESSION OF HUMAN-TUMOR NECROSIS FACTOR AND COMPARISON WITH MOUSE-TUMOR NECROSIS FACTOR
    MARMENOUT, A
    FRANSEN, L
    TAVERNIER, J
    VANDERHEYDEN, J
    TIZARD, R
    KAWASHIMA, E
    SHAW, A
    JOHNSON, MJ
    SEMON, D
    MULLER, R
    RUYSSCHAERT, MR
    VANVLIET, A
    FIERS, W
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1985, 152 (03): : 515 - 522
  • [10] PARANT M, 1987, CR ACAD SCI III-VIE, V304, P1